Pharming Group Gears Up for June Investor Conferences 2025

Author: Dylan Bailey Updated: 05-28-2025 02:02 AM

Pharming Group N.V. Engages with Investors this June

Pharming Group N.V. is excited to announce its participation in several upcoming investor conferences this June, where management will showcase their commitment to innovation and healthcare. Pharming, known for its dedication to developing treatments for rare diseases, aims to connect with investors the world over.

Highlighting Key Conferences in June

Among the notable events, Pharming will have a significant presence at the Jefferies Global Healthcare Conference 2025, taking place in New York. On June 5, CEO Fabrice Chouraqui will engage attendees in a Fireside Chat Q&A session scheduled for 2:00 PM EDT. This interactive discussion will allow investors to gain insights into the company’s vision and strategic initiatives.

Additional Conference Engagements

Following the New York event, Pharming will participate in the Portzamparc (BNP Paribas) Mid & Small Caps Conference in Paris on June 18. This conference is another opportunity for Pharming to network with potential investors and partners, further emphasizing their continual growth and dedication to the biopharmaceutical sector.

Connect with Pharming’s Management

Investors interested in learning more about these conferences, or those wishing to schedule a one-on-one meeting with Pharming’s management team, can reach out to the Investor Relations team. They are accessible via email and are eager to assist in any inquiries regarding these crucial events.

About Pharming Group N.V.

Pharming Group N.V. is a leading biopharmaceutical company committed to transforming the lives of patients suffering from rare, debilitating diseases. With a focus on both small molecules and biologics, Pharming is dedicated to developing a portfolio of innovative therapies. Headquartered in Leiden, Pharming operates in more than 30 markets across North America, Europe, the Middle East, Africa, and Asia-Pacific, making a positive impact on patient care worldwide.

Innovation at the Core

With its state-of-the-art research and development capabilities, Pharming continually strives to enhance the quality of life for patients. Their focus is not only on commercialization but also on the discovery of new treatments that address unmet medical needs.

Frequently Asked Questions

What is Pharming Group N.V.?

Pharming Group N.V. is a biopharmaceutical company focused on developing treatments for rare diseases and conditions.

Which conferences will Pharming be attending in June?

Pharming will attend the Jefferies Global Healthcare Conference and the Portzamparc Mid & Small Caps Conference.

How can investors schedule a meeting with Pharming's management?

Investors can contact Pharming's Investor Relations team via email for meeting requests during the conferences.

Who is the CEO of Pharming?

The CEO of Pharming is Fabrice Chouraqui, who will be speaking at the upcoming conferences.

What markets does Pharming operate in?

Pharming operates in over 30 markets globally, including regions like North America, Europe, and Asia-Pacific.

About The Author

My name is Dylan Bailey, and I am 28 years old. I am an author and an expert on the stock market who specializes in publicly traded companies. Early fascination with the stock market inspired me to seek a finance degree and then delve deeply into the world of stocks. I have developed over the years my abilities to spot investment prospects, assess business performance, and analyze market trends.

My books and articles try to help regular investors understand the nuances of the stock market. Anyone can, in my opinion, make wise investment choices and succeed financially if they have the correct information and resources. In my writing, I combine in-depth research with practical insights and advice that can be put into action. This is done with the intention of assisting readers in navigating the constantly shifting landscape of publicly traded companies.

In addition to writing, I also host webinars and workshops, where I give presentations and share my knowledge with a wider audience. I also write for top financial journals and show up as a guest analyst on financial news shows. I like to travel, spend time with my family, and keep active by playing different sports when I'm not buried in market research.

My goal is to enable people to choose wisely and consciously in their investments, so taking charge of their financial futures. By my work, I hope to create a community of informed and self-assured investors prepared to take advantage of the chances presented by the stock market.

Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.